Alemtuzumab-induced immune phenotype and repertoire changes: implications for secondary autoimmunity.
Ruck T, Barman S, Schulte-Mecklenbeck A, Pfeuffer S, Steffen F, Nelke C, Schroeter CB, Willison A, Heming M, Müntefering T, Melzer N, Krämer J, Lindner M, Riepenhausen M, Gross CC, Klotz L, Bittner S, Muraro PA, Schneider-Hohendorf T, Schwab N, Meyer Zu Hörste G, Goebels N, Meuth SG, Wiendl H.
Ruck T, et al. Among authors: gross cc.
Brain. 2022 Jun 3;145(5):1711-1725. doi: 10.1093/brain/awac064.
Brain. 2022.
PMID: 35661859
Free PMC article.